Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with Studio 512 about offering help to people who are experiencing peripheral neuropathy as a side effect of chemotherapy ...
Patients receiving chemotherapy-induced peripheral neuropathy experience persistent, clinically significant symptoms months after treatment.
A French-American research team discovered that the investigational compound Carba1 may prevent chemotherapy-induced peripheral neuropathy (CIPN) in preclinical models. According to a study published ...
In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). Study: Preventive ...
Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.
Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial All alive individuals diagnosed with CRC ...
Osmol Therapeutics E.U. Patent Allowance for Novel Therapy Targeting Chemotherapy-induced Neuropathy
NEW HAVEN, Conn., June 16, 2025 (GLOBE NEWSWIRE) -- Osmol Therapeutics, a privately held clinical-stage biopharmaceutical company focused on developing preventative treatments for chemotherapy-induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results